Strumento inattivo

Azioni Cascadian Therapeutics Inc (USA)

Azioni

Durata

Periodo

Stile

Cascadian Therapeutics Announces 2018 Outlook and Recent Progress	04/01/18
Cascadian Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency	02/01/18
Cascadian Therapeutics Added to the Nasdaq Biotechnology Index	13/12/17
Prolonged Progression-Free Survival Reinforces Tucatinib’s Potential for Patients with Advanced HER2+ Metastatic Breast Cancer	07/12/17
Cascadian Therapeutics Reports Third Quarter 2017 Financial Results	08/11/17

Settore

	Variaz. 1 gen.	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-2,31%	103 Mrd
REGENERON PHARMACEUTICALS, INC.	+0,56%	95,28 Mrd
ARGENX SE	+1,69%	22,15 Mrd
BIONTECH SE	-17,37%	21,02 Mrd
GENMAB A/S	-9,30%	18,15 Mrd
WUXI APPTEC CO., LTD.	-41,01%	16,74 Mrd
BEIGENE, LTD.	-14,85%	16,05 Mrd
NEUROCRINE BIOSCIENCES, INC.	+3,21%	13,68 Mrd
SAREPTA THERAPEUTICS, INC.	+33,54%	12,17 Mrd